High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2.

Thyroid 2000;10:31–9. 6. Sapin R. Serum thyroxine binding capacity-dependent bias in five free thyroxine immunoassays: assessment with serum dilution experiments and impact on diagnostic performance. Clin Biochem 2001;34:367–71. 7. Christofides ND. Free analyte immunoassay. In Wild D, ed. The immunoassay handbook, 2nd ed. London: Nature Publishing Group, 2001:61–77. 8. Christofides ND, Wilkinson E, Stoddart M, Ray DC, Beckett GJ. Assessment of serum thyroxine binding capacity-dependent biases in free thyroxine assays. Clin Chem 1999;45:520–5. 9. D’Herbomez M, Forzy G, Gasser F, Massart C, Beaudonnet A, Sapin R. Clinical evaluation of nine free thyroxine assays: persistent problems in specific physiopathological situation. Clin Chem Lab Med 2003;41:in press. 10. Frantz CR, Dagogo-Jack S, Ladenson JH, Gronowski AM. Thyroid function during pregnancy. Clin Chem 1999;45:2250–8. 11. Stockigt JR. Free thyroid hormone measurement: a critical appraisal [Review]. Endocrinol Metab Clin North Am 2001;30:265–89. 12. Roti E, Gardini E, Minelli R, Bianconi L, Flisi M. Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns. J Endocrinol Invest 1991;14: 1–9. 13. Van Blerk M, Smitz J, Rozenski E, Mees M, Roelandt P, Laermans L, et al. Four radioisotopic immunoassays of free thyroxine compared. Ann Clin Biochem 1996;33:335–43. 14. McElduff A. Measurement of free thyroxine (T4) in pregnancy. Aust NZ J Obstet Gynaecol 1999;39:158–61. 15. Panesar NS, Li CY, Rogers MS. Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem 2001;38:329–32. 16. Liewendahl K. Thyroid function tests: performance and limitations of current methodologies. Scand J Clin Lab Invest 1992;52:435–45. 17. Jaume JC, Mendel CM, Frost PH, Greenspan FS, Laughton CW. Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum free thyroxine concentration as measured by equilibrium dialysis. Thyroid 1996;6:79–83. 18. Stevenson HP, Archbold GPR, Johnston P, Young IS, Sheridan B. Misleading serum free thyroxine results during low molecular weight treatment. Clin Chem 1998;44:1002–7. 19. Sapin R, Schlienger JL, Gasser F, Noël E, Lioure B, Grunenberger F, et al. Intermethod discordant free thyroxine measurements in bone marrowtransplanted patients [Technical Brief]. Clin Chem 2000;46:418–22. 20. Midgley JEM. Direct and indirect free thyroxine assay methods: theory and practice [Review]. Clin Chem 2001;47:1353–63. 21. Saw S, Sethi S, Aw TC. Technical evaluation of thyroid assays on the Vitros ECi [Technical Brief]. Clin Chem 1999;45:578–80. 22. Langton JE, Brent GA. Non thyroidal illness syndrome: evaluation of thyroid function in sick patients [Review]. Endocrinol Metab Clin North Am 2002;31:159–72.